IGM Biosciences to Present at Three Upcoming Investor Conferences
MOUNTAIN VIEW, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that management will present…
НАУЧНОИЗСЛЕДОВАТЕЛСКА И РАЗВОЙНА ДЕЙНОСТ ПРЕЗ 2023 ГОДИНА сериозно спада като дял от БВП!
НАУЧНОИЗСЛЕДОВАТЕЛСКА И РАЗВОЙНА ДЕЙНОСТ ПРЕЗ 2023 ГОДИНА сериозно спада като дял от БВП! Това би трябвало да е много добра новина за нашето ВРЕДИТЕЛСТВО. Бълването на фалшиви новини е невероятно.…
Kforce Inc. Announces Participation in the UBS Global Technology and AI Conference
TAMPA, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Kforce Inc. (NYSE: KFRC), a provider of professional staffing services and solutions, today announced that management will participate in the UBS Global…
Phunware To Acquire Stake in Campaign Nucleus Subsidiary
AUSTIN, Texas, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Phunware, Inc. (NASDAQ: PHUN), a leader in enterprise cloud solutions for mobile applications, announced that it signed a term sheet, in conjunction…
Winner Automotive Group Expands Portfolio with Acquisition of Diver Chevrolet
WILMINGTON, Del., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Winner Automotive Group, a premier automotive group known for its commitment to exceptional customer service and a diverse selection of top-tier brands,…
Reopening of the tender period until november 8, 2024
PRESS RELEASE Ivry-sur-Seine, France — November 4, 2024, 6.00 p.m. CEST THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IS NOT…
Oruka Therapeutics to Present at Multiple November Investor Conferences
MENLO PARK, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment…
Réouverture de la période d’offre jusqu’au 8 novembre 2024
COMUNICATO STAMPA Ivry-sur-Seine, Francia — 4 novembre 2024, 18.00 CEST È VIETATA LA DIVULGAZIONE, LA PUBBLICAZIONE O LA DISTRIBUZIONE DEL PRESENTE COMUNICATO, IN TUTTO O IN PARTE, IN O VERSO…
Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of Directors
ALPHARETTA, Ga., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal…
Capital Southwest Announces Proposed Convertible Notes Offering
DALLAS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (Nasdaq: CSWC) (“Capital Southwest”) today announced the commencement of a registered public offering of unsecured convertible notes due 2029 (the…